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Abstract
Objective To identify morphologically the locations of equine corneal epithelial stem
cells (CESCs) and to culture these cells.
Animals studied We studied the eyes of 12 adult thoroughbred horses.
Procedures Eye tissues were immunostained for two positive stem cell markers (p63,
CK14) and one negative marker (CK3) to identify the locations of CESCs, so we
could compare their immunostaining patterns with those of human stem cells previ-
ously reported. We compared the proliferation rates and morphological features of
epithelial cells isolated from the corneal limbus and central cornea.
Results Undifferentiated cells expressing the same immunostaining pattern as human
CESCs were present in the equine corneal limbus. Cultured epithelial cells isolated
from the limbus expressed the same immunostaining pattern that CESCs show histo-
logically, but cells isolated from the central cornea did not proliferate and could not
be evaluated.
Conclusions Equine CESCs were localized in the epithelial basal layer of the corneal
limbus, where melanocytes reside. They could be cultured without loss of their undif-
ferentiated nature. When collecting such stem cells, it may be useful to harvest and
culture corneal epithelial tissues in the limbus where melanocytes serve as an indicator
of the collecting area.
Key Words: corneal epithelial cells, corneal epithelium, horse, limbus, localization of
corneal epithelial stem cells, stem cell
INTRODUCTION
Racehorses have a high incidence of corneal injuries
because their proximity to each other when racing can
result in trauma. Over 3000 Japanese racehorses experi-
enced corneal disorders in the 12 years from 1997 to
2008.1 Most of these cases were superficial traumatic
ulcers caused by injury from materials on the track surface
kicked up by other horses during races. Some horses with
these injuries take a long time to heal and return to rac-
ing.1 Others end their careers early because of reduced
vision due to scars and opacity in the cornea, even if they
do not become blind.
There are a number of therapeutic approaches to such
medically uncontrollable corneal disorders in horses,
including amniotic membrane transplantation and pene-
trating keratoplasty.2–4 Targeted lamellar keratoplasty was
reported recently as being a successful therapy.5 However,
most of these treatments use allotransplantation, which
has associated problems with graft rejection and difficul-
ties in maintaining a stable supply of grafts.4,6,7
In humans, cultivated corneal epithelial transplantation
has been used recently in the treatment for intractable
corneal disorders, such as those associated with Stevens–
Johnson syndrome.8–12 This method of transplantation is
minimally invasive for donor eyes, because grafts can be
prepared from small tissue fragments containing stem
cells. Therefore, even for human patients whose corneal
epithelial stem cells (CESCs) are extensively and severely
damaged, grafts for autotransplantation can still be pre-
pared as long as even small amounts of stem cells remain.
Furthermore, not only corneal epithelium but also oral
mucosal epithelium could be sufficient as sources of stem
cells.8–17 Cultivated corneal epithelial transplantation can
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simultaneously solve many of the problems associated with
allotransplantation, such as posttransplantation rejection
and the shortage of donors.3,4,17,18 It is also known that
human CESCs reside in the basal region of the limbus
and are involved in the renewal and regeneration of the
corneal epithelium.17,19,20
To our knowledge, there have been no reports of the
localization of equine CESCs or of cultivated corneal epi-
thelial transplantation in horses. As the tissue repair pro-
cess in equine corneal disorders is similar to that in
humans, we can infer that equine CESCs and their niche
should be present in the equine corneal limbus and that,
as in humans, they are involved in the maintenance of cor-
neal repair and homeostasis.21–23
The objective of this study was to identify morphologi-
cally the location of equine CESCs based on the assump-
tion that they reside in the basal epithelial layer of the
corneal limbus, as in humans. A further objective was to
obtain CESCs from among the equine limbal epithelial
cells (ELECs) on the basis of this hypothesis and culture
them.
MATERIALS AND METHODS
Cross-reactivity of primary anti-human antibodies with
horse
To immunohistochemically identify equine CESCs, we
selected three stem cell markers, p63, cytokeratin (CK) 14,
and CK3. The p63 and CK14 are positive markers for
general stem cells in humans, and CK3, a corneal epithe-
lial differentiation–associated marker, is a negative marker
for CESCs.8,10,24–28 Although anti-human p63 and CK14
antibodies are known to cross-react with horse epithelium,
there are no reports of cross-reactivity of anti-human CK3
antibody.29,30 Therefore, we confirmed that anti-human
CK3 antibody would also cross-react with equine corneal
epithelium by immunoblotting.
We used frozen human corneal tissues supplied by
SightLife Eye Bank (Seattle, WA, USA) and frozen equine
corneal tissues collected from an adult thoroughbred horse
for samples. These frozen tissues were pulverized by mixer
mill (MM200; Retsch GmbH, Hann, Germany) under
freezing conditions. Next, total proteins from each sam-
ples were extracted in manufactured SDS sample buffer
(B7709S; New England BioLabs, Ipswich, MA, USA) with
protease inhibitors (Complete Mini Protease Inhibitor
Cocktail Tablets; Roche Diagnostics GmbH, Mannheim,
Germany), followed by centrifugation at 4 °C, 12 000 9 g
for 5 min to collect the supernatant which was boiled at
100 °C for 5 min.29 Each protein was separated by SDS-
PAGE and transferred to polyvinylidene difluoride mem-
brane. Immunoblots were blocked with 2.5% casein and
incubated with anti-human CK3 antibody (AE5; Progen
Biotechnik GmbH, Heidelberg, Germany) (1:400), fol-
lowed by alkaline phosphatase–conjugated anti-mouse IgG
secondary antibody (1:100). Then, the electrophoretic
membrane was colorized by nitro blue tetrazolium (NBT/
BCIP solution kit; Nakarai Tesque, Kyoto, Japan) to
enhance visualization.
Localization of CESCs in the equine corneal limbus
Eyeballs were collected from adult thoroughbred horses
that were being killed in a slaughterhouse and were imme-
diately transported to our laboratory in phosphate-
buffered saline. After confirming that the tissues were free
of disease by gross macroscopic examination, we dissected
the eyeballs transversely and fixed them overnight in
methacarn fixative (methanol–chloroform–acetic acid at a
volume ratio of 6:3:1). These steps were completed within
1 h after death. The trimmed and fixed eyeballs were
embedded in paraffin blocks and sectioned at 4-lm thick-
ness. We immunohistochemically identified the locations
of three proteins in the corneal limbus: p63, cytokeratin
(CK) 14, and CK3. Before immunostaining, sections were
pretreated with ‘target retrieval solution’ (pH 9; Dako,
Glostrup, Denmark) for p63 and 6 M urea for CK14 and
CK3. Following retrieval of antigens, sections were pre-
pared with 0.5% periodic acid for blocking of endogenous
peroxidase activity and 0.5% casein to block nonspecific
binding. Then, sections were reacted with the each pri-
mary antibody, anti-p63 antibody (4A4; Dako, Glostrup,
Denmark) (1:250), anti-CK14 antibody (LL002; Novocas-
tra Laboratories Ltd, Newcastle, UK) (1:40), and
anti-CK3 antibody (AE5; Progen Biotechnik GmbH,
Heidelberg, Germany) (1:50). As secondary antibodies,
fluorescein isothiocyanate–conjugated polyclonal rabbit
anti-mouse immunoglobulins (Dako, Glostrup, Denmark)
(1:40) were used. Finally, after nuclear counterstaining
with propidium iodide, we observed sections using confo-
cal laser scanning microscopy (LSM510; Carl Zeiss
GmbH, Jena, Germany).
Isolation and culture of equine corneal epithelial cells
Corneal epithelial tissues were harvested from the horses
as described previously (n = 7) and from adult thorough-
bred horses euthanized for reasons other than ocular dis-
ease at the Equine Research Institute of the Japan Racing
Association (n = 5). The tissue was divided into 2 groups:
Tissue harvested from the corneal limbus and containing
ELECs (group L, n = 12) and tissue harvested from the
central cornea and containing no ELECs (group C,
n = 12). A 50-mm2 piece of corneal epithelium was col-
lected from each of the limbi and central corneas of the
same eye of each horse at the same time. In group L, after
removal of the conjunctiva from the corneal limbus with
corneal scissors, we performed a lamellar keratectomy of
the limbal epithelium, stripping a piece 1 mm wide by
50 mm long with an ophthalmic scalpel. In group C, we
performed a lamellar keratectomy of the central
epithelium, stripping a piece 5 mm wide by 10 mm long
with an ophthalmic scalpel. Corneal epithelial cells
(CECs) were isolated from these tissues using dispase II
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(1000 U/mL GD81070; Sanko Junyaku Co., Ltd.; now Ei-
dia Co., Ltd., Tokyo, Japan) and a 0.25% trypsin EDTA
solution (Gibco, Grand Island, NY, USA). The isolated
cells were plated onto a 35-mm-diameter culture plate
(which had been preseeded with feeder cells) at a density
of 2 9 104 cells/well. They were then cocultured with
standard supplemented hormone epithelial medium
(SHEM), consisting of Dulbecco’s modified Eagle’s med-
ium (D6429; Sigma, St. Louis, MO, USA), Ham’s F12
(N6658; Sigma), fetal bovine serum (Equitech-Bio, Kerr-
ville, TX, USA), penicillin–streptomycin (Gibco, Grand
Island, NY, USA), insulin (Wako, Osaka, Japan), cholera
toxin (227041; Calbiochem, Darmstadt, Germany), genta-
micin (Gibco, Grand Island, NY, USA), hydrocortisone
(Wako, Osaka, Japan), dimethylsulfoxide (D2650; Sigma),
and epidermal growth factor (Invitrogen, Grand Island,
NY, USA).9,19,31 Plating was completed within 6 h after
death. The SHEM medium was exchanged three times
per week throughout the culture period. The proliferation
rate and morphological features of the cultured cells were
observed and recorded until confluence occurred.
To prepare the feeder cells, we plated NIH/3T3 mouse
fibroblasts treated with 8 lg/mL mitomycin-C at a density
of 2 9 105 cells/well and incubated them at 37 °C for
1 h, then cultured them for 24 h at 37 °C in 5% CO2–
95% air.
To identify the immunohistochemical staining patterns
of the cultured cells, we additionally plated the cells at
1.66 9 104 cells/well onto 2-well chamber slides
(20 mm 9 20 mm) preseeded with feeder cells and then
cocultured them in standard SHEM medium as
above.9,19,31 When confluence was achieved (day 22), the
cells were immunostained for p63 (1:125), CK14 (1:40),
and CK3 (1:50) as described previously.
RESULTS
Cross-reactivity of primary anti-human antibodies with
horse
Both horse and human samples reacted with anti-human
CK3 antibody to produce a band of approximately the
same size (Fig. 1).
Localization of CESCs in the equine corneal limbus
In sections stained for p63, the nuclei of 2–3 layers of cor-
neal epithelial basal cells located apically from the basolat-
eral side stained positive, consistent with the region where
melanocytes are present in the corneal limbus, (Fig. 2b,B).
Figure 1. Immunoblotting of corneal epithelium with anti-CK3
antibody (AE5). Lane A, human; B, horse. Markers are about the
same molecular weight.
(a)
(b)
(c)
(d)
(A)
(B)
(C)
(D)
Figure 2. Distribution of cells expressing stem cell markers in the
corneal limbus. (Capital letters indicate higher magnification of
images labeled with lower-case letters.) Stains: (a, A) hematoxylin and
eosin, (b, B) anti-p63, (c, C) anti-CK14, and (d, D) anti-CK3. Nuclei
were costained with propidium iodide (red in c, C, d, D). p63
expression was evident in the nuclei of the basal epithelium in the
limbus (green in b, B). CK14 expression was evident in the cytoplasm
of the basal epithelium in the limbus (green in c, C). CK3 expression
was evident in other epithelium, but not in the basal epithelium in
the limbus (green in d, D).
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In sections stained for CK14, again the cytoplasms of 3–4
layers of corneal epithelial basal cells located apically from
the basolateral side were uniformly densely stained, consis-
tent with the region where melanocytes are present in the
corneal limbus (Fig. 2c,C). In sections stained for CK3,
the cytoplasms of all CECs except for 4–6 layers of basal
cells in the region where melanocytes are present in the
corneal limbus were densely stained. The staining was
strongest in the cells in the interlayers and tended to be
weaker in the cells on the apical side as well as in the basal
layer (Fig. 2d,D).
Isolation and culture of equine CECs
We collected 2.01  0.67 (SD) 9 106 nucleated cells from
the 50-mm2 tissue samples from group L and
0.730  0.034 9 106 nucleated cells from group C sam-
ples. Group L cells formed colonies several days after
plating in 10 of the 12 samples, and confluence on the
culture plate occurred at day 21.7  4.4 (SD) (Table 1).
In the remaining 2 samples, proliferation stopped after
colonies were formed. The cells in group C formed a few
colonies, but confluence was never reached in any of the
12 samples.
The colonies of group L were approximately circular
and were composed of cells of relatively small and uniform
size (Fig. 3a). They developed closely apposed polygonal
cells with a cobblestone-like morphology characteristic of
epithelial cells (Fig. 3c). The colonies of group C had a
distorted shape and were composed of larger cells that
were inconsistent in size (Fig 3b,d).
Immunohistochemistry could only be performed on
group L cells, which consisted of ELECs. Cultured
ELECs stained for p63 showed staining in the nuclei of
almost all of the cells, tending to be stronger in smaller
cells (Fig. 4b). The cytoplasms of nearly all cells stained
for CK14 were uniformly densely stained (Fig. 4c). Only a
few large cells showed faint staining for CK3, and most
were not stained (Fig. 4d).
DISCUSSION
To collect CESCs for the preparation of autografts for
cultivated corneal epithelial transplantation in horses, we
first needed to identify their location in the cornea. We
hypothesized that they reside in the basal layer of the lim-
bic epithelium, at the junction between the cornea and
sclera as in human eyes. In cross-sectional samples that
included the sclera, limbus, and cornea, we successfully
located them by immunostaining with three stem cell
markers.
Human CESCs are characterized by their expression of
markers such as p63, CK14, CK19, ABCG2, and integrin
a9, and the absence of corneal epithelial differentiation–
associated markers such as CK3 and CK12.10,25 Moreover,
they are slow-cycling cells.32 p63, which we used as a posi-
tive marker, is a nuclear transcription factor within the p53
family. p63 is deeply involved in the proliferative potential
of human keratinocytes, being expressed in the basal cells
of various human epithelial tissues, and is a stem cell
marker.13,14,24–26,31,33 CK14 is useful for identifying epi-
thelial progenitor cells with basal cell activity and is also a
stem cell marker.10 In contrast, CK3 is not expressed in
the basal layers of the limbal epithelium but is expressed in
the mature corneal epithelium; therefore, the absence of
CK3 is consistent with cells that may be CESCs.10,34
Among these stem cell markers, anti-human p63 and
CK14 antibodies were previously known to cross-react
with equine epithelium, and we confirmed that CK3 anti-
body cross-reacts with equine corneal epithelium in this
study. So, it may be useful to identify equine CESC using
these three stem cell markers as is done in humans.
Table 1. Days required for corneal epithelial cells isolated from each
group to reach confluence (35-mm culture plate; seeding density,
2 9 104)
Horse No. Group L Group C
1 27 –
2 16 –
3 30 –
4 18 –
5 22 –
6 20 –
7 25 –
8 16 –
9 – –
10 21 –
11 – –
12 22 –
Mean  SD (tissues/total) 21.7  4.4 (10/12) ND (0/12)
–: Confluen ce was not reached.
(a) (b)
(c) (d)
Figure 3. Colony characteristics of cells isolated and cultured from
groups L and C, and cell morphologies. (a) Colonies of group L at
day 7. (b) Colonies of group C at day 9. (c) Cell morphology of
group L at day 16. (d) Cell morphology of group C at day 16.
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Equine corneal immunostaining showed positive expres-
sion of p63 and CK14 in the epithelial basal layer but
negative expression of CK3, consistent with the region of
the limbus where melanocytes reside. This expression pat-
tern is similar to that of epithelial basal cells of the cor-
neal limbus, which are considered in humans to be
CESCs, thus indicating that CESCs are also distributed in
the epithelial basal layer of the equine corneal limbus.10
Moreover, CESCs expressing these markers are not seen
in any regions other than the limbus, suggesting that the
distribution of CESCs in horses is more similar to that of
humans or rats than to that of mice.19,35–38 Specifically,
the ELECs contain equine CESCs and undifferentiated
cells close to those stem cells, whereas the CECs in the
central region consist of advanced differentiated cells clo-
ser to terminal differentiated cells. In horses, as in
humans, we can infer that tissue repair and homeostasis
are maintained as CESCs included among the ELECs
migrate toward the central cornea while differentiating
into terminal differentiated cells.
In humans, the basal layer of corneal epithelium, in
which CESCs are thought to reside, contains a wrinkled
structure referred to as the palisades of Vogt (POV).39 In
people with pigmented skin, the POV are easily visible
under a magnifying loupe because of the deposition of
melanin pigment. Identification of the POV structure
macroscopically is considered to be a simple and conve-
nient clinical indicator of the presence or absence of
CESCs.39 On the other hand, in the horse eyeball, which
lacks the POV, the distribution of CESCs expressing p63
and CK14 and not expressing CK3 corresponds approxi-
mately to the region containing melanocytes in the limbal
corneal epithelium, suggesting that ELECs that include
stem cells can be efficaciously harvested using melanocytes
as a location indicator.
The CECs in group L showed high proliferative activity
in 10 of 12 tissue samples, whereas in group C, which did
not contain ELECs, proliferation stopped in all samples.
This indicates a clear difference in proliferative potential
and colony characteristics between the two groups. It is
well known that small keratinocytes are capable of active
proliferation and that proliferation becomes less active as
the cell becomes larger.40 Furthermore, depending on dif-
ferences in colony-forming ability during single-cell cul-
ture of keratinocytes and in the frequency of terminal
colonies, there are three different clonal types: holoclone,
meroclone and paraclone.26,41 Differentiation advances
from the holoclone, which has higher proliferation poten-
tial and is closest to stem cells, to the meroclone and then
to the paraclone.41,42 This classification leads us to infer
that the small size and active proliferation potential of the
cells isolated from group L, which consisted of ELECs,
correspond to the features of holoclones. In contrast, the
large size and lower proliferation activity of the cells iso-
lated from the central cornea correspond to the features of
paraclones or meroclones, which are at a more advanced
stage of differentiation. These inferences suggest that the
ELECs isolated from the corneal limbus included stem
cells in large numbers.
To corroborate our inferences, we examined the expres-
sion patterns of the stem cell markers in cultured ELECs.
In cells stained for p63, the nuclei of almost all of the cul-
tured ELECs were stained, but small cells tended to be
more densely stained than large cells, suggesting that the
small cells had greater proliferative activity. In cells
stained for CK14, the cytoplasms of almost all of the cul-
tured ELECs were uniformly densely stained. In cells
stained for CK3, apart from a few large cells, no cultured
ELECs were stained. These expression patterns were the
same as those of CESCs localized in the corneal limbal
tissue, demonstrating that the cells grown from the
ELECs were equine CESCs. This result suggests that cul-
ture of ELECs isolated from the equine corneal limbus
allows the ELECs to proliferate while maintaining the
(a) (b) (c)
(d) (e) (f)
Figure 4. Immunohistochemistry of cultured
ELECs (day 22). (a–c) Single stains; (d–f) nuclei
were costained with propidium iodide (red).
Stains: (a) hematoxylin and eosin, (b) anti-p63
(green), (c) no stain (negative control), (d) anti-
CK14 (green), (e) anti-CK3 (green), (f) negative
control. p63 expression was confirmed in the
nuclei of almost all cultured ELECs. Cytoplasms
of all cultured ELECs uniformly expressed CK14
densely. A few large cells faintly expressed CK3,
but most did not.
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undifferentiated state of the CESCs included among the
ELECs.
We were able to grow ELECs to cover a 35-mm culture
dish from cells harvested from the corneal limbus and pla-
ted at only 2 9 104 cells/well. In the future, for clinical
application of cultivated corneal epithelial transplantation
and to allow for processing losses, it should be possible to
prepare a cultured cell sheet for transplantation even if only
1-mm2 of limbal epithelial tissue remains in the donor.
In conclusion, we have shown that CESCs required for
the preparation of cultured equine CEC sheets are local-
ized in the epithelial basal layer of the corneal limbus
where melanocytes reside. Moreover, we showed that
ELECs including undifferentiated CESCs can be isolated
by harvesting corneal epithelial tissue identified in associa-
tion with melanocytes. We further found that by culturing
the isolated ELECs, the CESCs among them could be
cultured without loss of their undifferentiated state.
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